Gyre Therapeutics (GYRE) Capital Expenditures Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 27.92% |
| Jun 30, 2025 | 74.11% |
| Mar 31, 2025 | 48.31% |
| Dec 31, 2024 | -130.45% |
| Sep 30, 2024 | 269.95% |
| Jun 30, 2024 | 97.06% |
| Mar 31, 2024 | 72.78% |
| Dec 31, 2023 | 67.74% |
| Jun 30, 2023 | 283.14% |
| Mar 31, 2023 | 54.48% |
| Sep 30, 2021 | 86.17% |
| Dec 31, 2018 | 40.28% |
| Jun 30, 2018 | -32.87% |
| Mar 31, 2018 | 23.12% |
| Dec 31, 2017 | -36.58% |
| Mar 31, 2017 | -42.07% |
| Dec 31, 2016 | -13.50% |
| Sep 30, 2016 | -33.33% |
| Jun 30, 2016 | -10.71% |
| Mar 31, 2016 | -31.68% |
| Dec 31, 2015 | -42.88% |